GAO on BSE
This article was originally published in The Tan Sheet
HHS Secretary Tommy Thompson should consider whether "food, cosmetics and OTC drugs should be labeled to advise consumers that the products may contain central nervous system tissue," according to a 1GAO report released Feb. 26 on U.S. regulatory efforts to prevent mad cow disease. "Consumers do not always know when foods and other products they use may contain central nervous system tissue, which, according to scientific experts, could pose a health risk if taken from diseased animals," GAO says. Report notes FDA is considering banning CNS tissue from foods, cosmetics, OTCs. GAO also recommends FDA, USDA strengthen animal feed ban enforcement, develop coordinated strategy to identify resources needed to increase import inspections...
You may also be interested in...
Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.
Latest warnings also include second and third businesses in US cannabidiol and hemp sector found making unlawful claims for treating and preventing COVID-19. Four of five firms warned apparently responded by removing violative claims from websites and social media posts.
In addition to our daily in-depth coverage of key regulatory events relating to the coronavirus pandemic, we’re bringing you selected brief insights into the impact on biopharma commercial activities.